BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0559 reviews
Vote for Target Test Prep, Newsweek Readers’ Choice Awards 2026
NEWSWEEK READERS’ CHOICE 2026

BIG NEWS! Target Test Prep has been nominated, and they’d love your vote!

TTP has worked incredibly hard to build the best test prep experience possible, and winning Newsweek’s 2026 Readers’ Choice Award for Best Test Prep would mean a lot to them. If TTP has helped you, they’d be incredibly grateful for your vote. You can vote once each day through September 9.

Vote for TTP
GMATLiveTeach 7 seats left
Chris Peckover
NEXT LIVE COHORT

Oct 13 to Jan 7, 2027

with Chris Peckover

Schedule
Tue, Thu · 8:00 to 10:00 PM ET
Included
40 live hours + 6 months of GMAT OnDemand
  • Live instruction and real-time questions
  • Class recordings and assigned practice
View class & enroll
Limited cohort · enrollment openTarget Test Prep
EALiveTeach 5 seats left
Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll
Limited cohort · enrollment openTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

A new drug, taken twice daily for one month

Expert replies
by NandishSS » Sun May 21, 2017 11:45 pm
A new drug, taken twice daily for one month, is an effective treatment for a certain disease. The drug now most commonly prescribed for the disease occasionally has serious side effects such as seizures; the new drug has side effects much more frequently, but the worst of them is mild nausea. Therefore, the new drug is clearly preferable as a treatment.

Which of the following, if true, most seriously weakens the argument?

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it.
B) People who experience nausea are prone to discontinue use of the new drug prematurely.
C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug.
D) People who have received effective treatment for disease do not generally contract the disease again.
E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.

OA:B

Source:GMATPrep EP2
Join the discussion
Source: — Critical Reasoning |

by GMATGuruNY » Mon May 22, 2017 4:05 am
NandishSS wrote:A new drug, taken twice daily for one month, is an effective treatment for a certain disease. The drug now most commonly prescribed for the disease occasionally has serious side effects such as seizures; the new drug has side effects much more frequently, but the worst of them is mild nausea. Therefore, the new drug is clearly preferable as a treatment.

Which of the following, if true, most seriously weakens the argument?

A) It is possible that the drug now most commonly prescribed has side effects that have not yet been attributed to it.
B) People who experience nausea are prone to discontinue use of the new drug prematurely.
C) Other drugs for the disease have typically been prescribed only for patients allergic to the most commonly prescribed drug.
D) People who have received effective treatment for disease do not generally contract the disease again.
E) There is a nonprescription medication that when taken with the new drug prevents the onset of nausea.
Premise: While the most commonly prescribed drug occasionally has serious side effects, the worst -- although much more frequent -- side effect of the new drug is mild nausea.
Conclusion: The new drug is clearly preferable as a treatment.

To weaken the conclusion, the correct answer choice must show that the new drug is NOT better than the most commonly prescribed drug.

B: People who experience nausea are prone to discontinue use of the new drug prematurely.
Here, the mild nausea frequently caused by the new drug is likely to induce many people to stop taking the drug, WEAKENING the conclusion that the new drug is better than the most commonly prescribed drug, which only OCCASIONALLY has serious side effects.

The correct answer is B.
Private tutor exclusively for the GMAT and GRE, with over 20 years of experience.
Followed here and elsewhere by over 1900 test-takers.
I have worked with students based in the US, Australia, Taiwan, China, Tajikistan, Kuwait, Saudi Arabia -- a long list of countries.
My students have been admitted to HBS, CBS, Tuck, Yale, Stern, Fuqua -- a long list of top programs.

As a tutor, I don't simply teach you how I would approach problems.
I unlock the best way for YOU to solve problems.

For more information, please email me (Mitch Hunt) at [email protected].
Student Review #1
Student Review #2
Student Review #3
Join the discussion